ARTL
Price
$0.96
Change
-$0.06 (-5.88%)
Updated
Dec 18, 04:59 PM (EDT)
98 days until earnings call
LSTA
Price
$2.64
Change
-$0.00 (-0.00%)
Updated
Dec 18, 03:33 PM (EDT)
98 days until earnings call
Ad is loading...

ARTL vs LSTA

Header iconARTL vs LSTA Comparison
Open Charts ARTL vs LSTABanner chart's image
Artelo Biosciences
Price$0.96
Change-$0.06 (-5.88%)
VolumeN/A
CapitalizationN/A
Lisata Therapeutics
Price$2.64
Change-$0.00 (-0.00%)
Volume$289
CapitalizationN/A
ARTL vs LSTA Comparison Chart
Loading...
ARTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARTL vs. LSTA commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTL is a Hold and LSTA is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ARTL: $1.02 vs. LSTA: $2.64)
Brand notoriety: ARTL and LSTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTL: 86% vs. LSTA: 201%
Market capitalization -- ARTL: $3.29M vs. LSTA: $22.2M
ARTL [@Biotechnology] is valued at $3.29M. LSTA’s [@Biotechnology] market capitalization is $22.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTL’s FA Score shows that 1 FA rating(s) are green whileLSTA’s FA Score has 1 green FA rating(s).

  • ARTL’s FA Score: 1 green, 4 red.
  • LSTA’s FA Score: 1 green, 4 red.
According to our system of comparison, ARTL is a better buy in the long-term than LSTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTL’s TA Score shows that 3 TA indicator(s) are bullish while LSTA’s TA Score has 1 bullish TA indicator(s).

  • ARTL’s TA Score: 3 bullish, 6 bearish.
  • LSTA’s TA Score: 1 bullish, 4 bearish.
According to our system of comparison, both ARTL and LSTA are a bad buy in the short-term.

Price Growth

ARTL (@Biotechnology) experienced а -8.11% price change this week, while LSTA (@Biotechnology) price change was -6.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Reported Earning Dates

ARTL is expected to report earnings on Mar 26, 2025.

LSTA is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LSTA($21.8M) has a higher market cap than ARTL($3.29M). LSTA YTD gains are higher at: -3.114 vs. ARTL (-27.143). ARTL has more cash in the bank: 12.1M vs. LSTA (5.88M). ARTL has less debt than LSTA: ARTL (127K) vs LSTA (172K).
ARTLLSTAARTL / LSTA
Capitalization3.29M21.8M15%
EBITDAN/AN/A-
Gain YTD-27.143-3.114872%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total Cash12.1M5.88M206%
Total Debt127K172K74%
FUNDAMENTALS RATINGS
ARTL vs LSTA: Fundamental Ratings
ARTL
LSTA
OUTLOOK RATING
1..100
510
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
13
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
6279
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
4195

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARTL's Valuation (12) in the null industry is in the same range as LSTA (13). This means that ARTL’s stock grew similarly to LSTA’s over the last 12 months.

ARTL's Profit vs Risk Rating (100) in the null industry is in the same range as LSTA (100). This means that ARTL’s stock grew similarly to LSTA’s over the last 12 months.

LSTA's SMR Rating (97) in the null industry is in the same range as ARTL (98). This means that LSTA’s stock grew similarly to ARTL’s over the last 12 months.

ARTL's Price Growth Rating (62) in the null industry is in the same range as LSTA (79). This means that ARTL’s stock grew similarly to LSTA’s over the last 12 months.

ARTL's P/E Growth Rating (100) in the null industry is in the same range as LSTA (100). This means that ARTL’s stock grew similarly to LSTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARTLLSTA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 13 days ago
80%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
ARTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ARTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTL has been loosely correlated with MTNB. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ARTL jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTL
1D Price
Change %
ARTL100%
-3.77%
MTNB - ARTL
37%
Loosely correlated
+10.16%
PALI - ARTL
34%
Loosely correlated
+3.26%
APLM - ARTL
31%
Poorly correlated
-8.87%
PHIO - ARTL
28%
Poorly correlated
-4.93%
LSTA - ARTL
28%
Poorly correlated
+1.38%
More

LSTA and

Correlation & Price change

A.I.dvisor tells us that LSTA and ASND have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LSTA and ASND's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSTA
1D Price
Change %
LSTA100%
+1.38%
ASND - LSTA
26%
Poorly correlated
+2.71%
ARTL - LSTA
26%
Poorly correlated
-3.77%
MRUS - LSTA
25%
Poorly correlated
+4.91%
CARA - LSTA
25%
Poorly correlated
-3.22%
OABI - LSTA
25%
Poorly correlated
-0.79%
More